Radcliffe Capital Management’s Coeptis Therapeutics Holdings, Inc. Warrants COEPW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-70,506
| Closed | -$5.25K | – | 475 |
|
|
2023
Q2 | $5.25K | Sell |
70,506
-2,694
| -4% | -$201 | ﹤0.01% | 497 |
|
|
2023
Q1 | $12K | Buy |
73,200
+35,700
| +95% | +$5.88K | ﹤0.01% | 507 |
|
|
2022
Q4 | $57.4K | Sell |
37,500
-37,400
| -50% | -$57.3K | ﹤0.01% | 869 |
|
|
2022
Q3 | $763K | Hold |
74,900
| – | – | 0.02% | 991 |
|
|
2022
Q2 | $755K | Hold |
74,900
| – | – | 0.02% | 1046 |
|
|
2022
Q1 | $756K | Hold |
74,900
| – | – | 0.02% | 1045 |
|
|
2021
Q4 | $749K | Hold |
74,900
| – | – | 0.02% | 908 |
|
|
2021
Q3 | $745K | Hold |
74,900
| – | – | 0.02% | 770 |
|
|
2021
Q2 | $739K | Hold |
74,900
| – | – | 0.02% | 792 |
|
|
2021
Q1 | $732K | Buy |
+74,900
| New | +$732K | 0.03% | 615 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 248 |
|